T Cell Dysfunction in Cancer Immunity and Immunotherapy

• Human CD34+-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8+ T cell and NK cell responses in vitro and in vivo

  2023 Cellular and Molecular Life Sciences article Immunology and Microbiology Immunotherapy and Immune Responses Open access

  4

  citations
• Breast Cancer Stem Cell–Derived Tumors Escape from γδ T-cell Immunosurveillance In Vivo by Modulating γδ T-cell Ligands

  2023 Cancer Immunology Research article Medicine Cancer Immunotherapy and Biomarkers Open access

  16

  citations
• Data from Breast Cancer Stem Cell–Derived Tumors Escape from γδ T-cell Immunosurveillance In Vivo by Modulating γδ T-cell Ligands

  2023 other Medicine Cancer Immunotherapy and Biomarkers Open access

  0

  citations
• Breast cancer stem cell-derived tumors escape from γδ T cell immunosurveillance in vivo by modulating γδ T cell ligands

  2022 bioRxiv (Cold Spring Harbor Laboratory) preprint Medicine Cancer Immunotherapy and Biomarkers Open access

  0

  citations
• Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer

  2020 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access

  21

  citations
• Helpless Priming Sends CD8+ T Cells on the Road to Exhaustion

  2020 Frontiers in Immunology article Immunology and Microbiology T-cell and B-cell Immunology Open access

  56

  citations

6 results